Chief Physician, Professor and Doctoral Supervisor, Deputy Director of the Department of Genitourinary Medical Oncology, Peking University Cancer Hospital. He is mainly engaged in multidisciplinary comprehensive treatment and translational research of genitourinary tumors such as renal cell carcinoma and bladder cancer, as well as malignant melanoma. He has accumulated rich clinical experience particularly in advanced renal cell carcinoma, urothelial carcinoma and mucosal malignant melanoma. As the principal investigator, he has completed numerous clinical studies on genitourinary tumors, especially advanced renal cell carcinoma, urothelial carcinoma and melanoma. His relevant work has been recognized by peers at home and abroad and incorporated into the NCCN Guidelines for Renal Cell Carcinoma, UK Guidelines for Head and Neck Mucosal Melanoma, and CSCO Guidelines for the Diagnosis and Treatment of Renal Cell Carcinoma, Urothelial Carcinoma and Melanoma. As a drafting author, he has participated in compiling multiple editions of CSCO guidelines for renal cell carcinoma, urothelial carcinoma and prostate cancer, contributing to the standardized diagnosis and treatment of genitourinary tumors in China, and was honored as Outstanding Young Scholar in Chinese Genitourinary Oncology. As the first or corresponding author, he has published multiple SCI papers in leading international oncology journals including The New England Journal of Medicine, JCO, JITC and CCR, with a cumulative impact factor of over 200. As a key participant, he has been awarded the Second Prize of Beijing Science and Technology Progress Award, Second Prize of Science and Technology Progress Award of Chinese Anti‑Cancer Association, Third Prize of Chinese Medical Association Science and Technology Award, and Third Prize of Huaxia Medical Award.